United States

Xiangxue Pharmaceutical Co Ltd (300147.SZ)

300147.SZ on Shenzhen Stock Exchange

25 May 2017
Change (% chg)

¥-0.11 (-1.09%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300147.SZ


Xiangxue Pharmaceutical Co., Ltd. is principally engaged in the production and distribution of Chinese patent medicine. The Company provides tablets, capsules, granules, oral liquids and aerosols, among others. The Company's major products include antiviral oral liquids and indigowoad root granules. The Company distributes its... (more)


Beta: 0.86
Market Cap(Mil.): ¥6,700.75
Shares Outstanding(Mil.): 661.48
Dividend: --
Yield (%): 1.18


  300147.SZ Industry Sector
P/E (TTM): 117.52 14.31 17.43
EPS (TTM): 0.09 -- --
ROI: 2.21 -7.26 -5.41
ROE: 1.66 -6.76 -4.69

BRIEF-Xiangxue Pharmaceutical unit to buy Chongqing-based medical firm from co for 2.6 mln yuan

* Says co's 51 percent owned Beijing-based pharmaceutical biotech unit plans to fully buy co's Chongqing-based medical unit at 2.6 million yuan

Apr 28 2017

BRIEF-Xiangxue Pharmaceutical unit to buy property in Wuhan at 167.3 mln yuan

* Says its unit enters into contract to buy a property (9574.05 square meter) located in Wuhan, at price of 167.3 million yuan

Apr 28 2017

BRIEF-Xiangxue Pharmaceutical issues 750 mln yuan super short-term debentures

* Says it issues 2017 first tranche super short-term debentures worth 750 million yuan with a term of 270 days and coupon rate of 5.6 percent

Mar 27 2017

BRIEF-Xiangxue Pharmaceutical sees Q1 FY 2017 net profit down 20 pct to 40 pct

* Sees Q1 FY 2017 net profit to decrease by 20 percent to 40 percent, or to be 18.9 million yuan to 25.2 million yuan

Mar 26 2017

BRIEF-Xiangxue Pharmaceutical plans new units and to invest in two firms

* Says its Hubei-based Chinese medicine subsidiary plans to set up wholly owned Chinese medicine tech unit in Hubei, with investment of 5 million yuan

Mar 20 2017

More From Around the Web

Earnings vs. Estimates